|
Trinity Biotech Plc (TRIB) |
|
|
|
Trinity Biotech Plc's Customers Performance
TRIB
|
TRIB's Source of Revenues |
During the corresponding time, Trinity Biotech Plc revenue deteriorated by -19.56 % year on year, While revenue at the Trinity Biotech Plc's corporate clients
• List of TRIB Customers
|
|
for the same period Trinity Biotech Plc revnue deteriorated by -19.56 % year on year,
• List of TRIB Customers
Select the Relationship:
|
|
Select the Category:
|
|
Trinity Biotech Plc's Comment on Sales, Marketing and Customers
News about Trinity Biotech Plc Contracts |
Trinity Biotech Plc Finalizes ADS Ratio Change, Offering Greater Value to InvestorsDublin, Ireland, Feb. 15, 2024 - Trinity Biotech Plc. (NASDAQ: TRIB), a leading biotechnology company, has announced the finalization of the effective date for its ratio change of its American depositary shares (ADSs). The change will now see one (1) ADS representing twenty (20) Class A ordinary shares, offering investors enhanced value and potential benefits. The ratio change is set to take place on February 23, 2024, on the Nasdaq Global Market, creating an exciting opportunity for both current and potential investors.This strategic move by Trinity Biotech Plc. aims to optimize the trading price of the ADSs and increase the ...
|
Trinity Biotech Announces Partnership with Bayer for Launch of CGM Biosensor Device in China and IndiaDublin, Ireland - January 31, 2024 - Trinity Biotech plc (Nasdaq: TRIB) has made an exciting revelation today as the company enters into a non-binding Letter of Intent with Bayer. This strategic partnership aims to launch a Continuous Glucose Monitoring (CGM) biosensor device in two of the largest and fastest-growing markets in the world - China and India. The collaboration comes on the heels of Trinity Biotech's recent acquisition of the CGM assets of Waveform Technologies, Inc., further solidifying the company's commitment to providing innovative solutions for diabetes management.Continuous Glucose Monitor...
|
Dublin-based medical diagnostics enterprise, Trinity Biotech, announced this week that they have commenced the shipping of their groundbreaking HIV screening test, TrinScreen HIV, to Kenya. This news comes as a significant development in the arena of disease diagnostics and marks a remarkable feat in the global fight against HIV/Aids.Trinity Biotech plc, a leading name in the development and manufacturing of diagnostic products for point-of-care and clinical laboratory markets, is known for its innovation in the medical field. The test, aptly named TrinScreen HIV, is the latest addition to its illustrious portfolio. This rapid HIV screening test is a testimony to the Company's pioneering technology and pursu...
|
TRIB's vs. Customers, Data
(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)
COMPANY NAME |
MARKET CAP |
REVENUES |
INCOME |
EMPLOYEES |
Trinity Biotech Plc |
67.90 |
74.78 |
-41.00 |
569 |
SUBTOTAL |
0.00 |
0.00 |
0.00 |
- |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved. This site uses cookies to make your browsing experince better. By
using this site, you agree to the Terms of Service and Privacy Policy - UPDATED
(Read about our Privacy Policy)
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com